Intraventricular Sialidase Administration Enhances GM1 Ganglioside Expression and Is Partially Neuroprotective in a Mouse Model of Parkinson’s Disease

Open Access

Peer-reviewed

Research Article

Jay S. Schneider ,

* E-mail: jay.schneider@jefferson.edu

Affiliation Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, PA, United States of America
⨯
Thomas N. Seyfried,

Affiliation Department of Biology, Boston College, Chestnut Hill, MA, United States of America
⨯
Hyo-S. Choi,

Affiliation Department of Biology, Boston College, Chestnut Hill, MA, United States of America
⨯
Sarah K. Kidd

Affiliation Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, PA, United States of America
⨯

Reader Comments (0)

Sphingolipids
Is the Subject Area "Sphingolipids" applicable to this article?

Thanks for your feedback.
Neurons
Is the Subject Area "Neurons" applicable to this article?

Thanks for your feedback.
Parkinson disease
Is the Subject Area "Parkinson disease" applicable to this article?

Thanks for your feedback.
Dopamine
Is the Subject Area "Dopamine" applicable to this article?

Thanks for your feedback.
Neuroprotectives
Is the Subject Area "Neuroprotectives" applicable to this article?

Thanks for your feedback.
Substantia nigra
Is the Subject Area "Substantia nigra" applicable to this article?

Thanks for your feedback.
Sialic acids
Is the Subject Area "Sialic acids" applicable to this article?

Thanks for your feedback.
Vibrio cholerae
Is the Subject Area "Vibrio cholerae" applicable to this article?

Thanks for your feedback.